Catalyst Wire Dossier Catalyst Wire Dossier

BEAM conditioning regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEAM conditioning regimen, covering 2018-02-13 to 2018-02-13. Get the full timeline:

Most recent: Clinical Trial Update: BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL [Phase 3]

See pricing